Clarke ML - Search Results

1

Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: clarke ml. Int J Cancer. 2002 Feb 1;97(4):439-45. doi: 10.1002/ijc.1628. Int J Cancer. 2002. PMID: 11802204

2

Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue.

Galmarini CM, Clarke ML, Santos CL, Jordheim L, Perigaud C, Gosselin G, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: clarke ml. Int J Cancer. 2003 Oct 20;107(1):149-54. doi: 10.1002/ijc.11339. Int J Cancer. 2003. PMID: 12925971

3

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.

Galmarini CM, Clarke ML, Jordheim L, Santos CL, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: clarke ml. BMC Pharmacol. 2004 May 24;4:8. doi: 10.1186/1471-2210-4-8. BMC Pharmacol. 2004. PMID: 15157282 Free PMC article.

4

The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.

Clarke ML, Mackey JR, Baldwin SA, Young JD, Cass CE. Clarke ML, et al. Cancer Treat Res. 2002;112:27-47. doi: 10.1007/978-1-4615-1173-1_2. Cancer Treat Res. 2002. PMID: 12481710 Review. No abstract available.

5

Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.

Damaraju VL, Bouffard DY, Wong CK, Clarke ML, Mackey JR, Leblond L, Cass CE, Grey M, Gourdeau H. Damaraju VL, et al. Among authors: clarke ml. BMC Cancer. 2007 Jul 3;7:121. doi: 10.1186/1471-2407-7-121. BMC Cancer. 2007. PMID: 17608948 Free PMC article.

6

Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.

Mackey JR, Jennings LL, Clarke ML, Santos CL, Dabbagh L, Vsianska M, Koski SL, Coupland RW, Baldwin SA, Young JD, Cass CE. Mackey JR, et al. Among authors: clarke ml. Clin Cancer Res. 2002 Jan;8(1):110-6. Clin Cancer Res. 2002. PMID: 11801546

7

Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.

Gourdeau H, Clarke ML, Ouellet F, Mowles D, Selner M, Richard A, Lee N, Mackey JR, Young JD, Jolivet J, Lafrenière RG, Cass CE. Gourdeau H, et al. Among authors: clarke ml. Cancer Res. 2001 Oct 1;61(19):7217-24. Cancer Res. 2001. PMID: 11585758

8

Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease.

Reiman T, Clarke ML, Dabbagh L, Vsianska M, Coupland RW, Belch AR, Baldwin SA, Young JD, Cass CE, Mackey JR. Reiman T, et al. Among authors: clarke ml. Leuk Lymphoma. 2002 Jul;43(7):1435-40. doi: 10.1080/1042819022386725. Leuk Lymphoma. 2002. PMID: 12389626

9

MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML.

Clarke ML, Gabrielsen OS, Frampton J. Clarke ML, et al. Adv Exp Med Biol. 2024;1459:341-358. doi: 10.1007/978-3-031-62731-6_15. Adv Exp Med Biol. 2024. PMID: 39017851 Review.

10

Towards the Industrial Implementation of Mn-based Catalyst for the Hydrogenation of Ketones and Carboxylic Esters.

Link A, Furer P, Clarke ML, Müller M. Link A, et al. Among authors: clarke ml. Chimia (Aarau). 2024 Mar 27;78(3):118-122. doi: 10.2533/chimia.2024.118. Chimia (Aarau). 2024. PMID: 38547012 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters